BHST
BioHarvest Sciences Inc. Common Stock
Agricultural Inputs
Market Cap$95M
5Y Perf.-11.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
BHST vs SIGA
Revenue, margins, valuation, and 5-year total return — side by side.
SIGA
SIGA Technologies, Inc.
Drug Manufacturers - Specialty & Generic
Market Cap$337M
5Y Perf.-34.9%
BHST vs SIGA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | BHST | SIGA |
|---|---|---|
| Industry | Agricultural Inputs | Drug Manufacturers - Specialty & Generic |
| Market Cap | $95M | $337M |
| Revenue (TTM) | $33M | $95M |
| Net Income (TTM) | $-12M | $23M |
| Gross Margin | 59.2% | 68.6% |
| Operating Margin | -18.8% | 25.1% |
| Forward P/E | — | 2.8x |
| Total Debt | $14M | $795K |
| Cash & Equiv. | $2M | $154.97T |
BHST vs SIGA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
BHST
SIGA
| Stock | Oct 24 | May 26 | Return |
|---|---|---|---|
| BioHarvest Sciences… (BHST) | 100 | 88.8 | -11.2% |
| SIGA Technologies, … (SIGA) | 100 | 65.1 | -34.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BHST vs SIGA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: SIGA leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. BioHarvest Sciences Inc. Common Stock is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
BHST
BioHarvest Sciences Inc. Common Stock
The Income Pick
BHST is the clearest fit if your priority is income & stability and growth exposure.
- beta 1.05
- Rev growth 98.8%, EPS growth 14.0%, 3Y rev CAGR 128.8%
- Lower volatility, beta 1.05, current ratio 0.55x
Best for: income & stability and growth exposure
SIGA
SIGA Technologies, Inc.
The Long-Run Compounder
SIGA carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 7.2% 10Y total return vs BHST's -16.0%
- 24.6% margin vs BHST's -36.3%
- 12.8% yield; 4-year raise streak; the other pay no meaningful dividend
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | BHST | 98.8% revenue growth vs SIGA's -31.8% |
| Quality / Margins | SIGA | 24.6% margin vs BHST's -36.3% |
| Stability / Safety | BHST | Beta 1.05 vs SIGA's 1.15 |
| Dividends | SIGA | 12.8% yield; 4-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | SIGA | +0.6% vs BHST's -35.9% |
| Efficiency (ROA) | SIGA | 0.0% ROA vs BHST's -41.5%, ROIC 0.0% vs -70.4% |
BHST vs SIGA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
BHST vs SIGA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLSIGALAGGINGBHST
BHSTBioHarvest Sciences I…
0leads
SIGASIGA Technologies, In…
4leads
6 Total Categories
CATEGORYLEADERvs BHSTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
SIGA4/6
Valuation MetricsMultiples, price ratios, and targets
SIGA2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
SIGA7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
SIGA6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
SIGA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SIGA is the larger business by revenue, generating $95M annually — 2.9x BHST's $33M. SIGA is the more profitable business, keeping 24.6% of every revenue dollar as net income compared to BHST's -36.3%. On growth, BHST holds the edge at +38.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | BHSTBioHarvest Scienc… | SIGASIGA Technologies… |
|---|---|---|
| RevenueTrailing 12 months | $33M | $95M |
| EBITDAEarnings before interest/tax | -$5M | $24M |
| Net IncomeAfter-tax profit | -$12M | $23M |
| Free Cash FlowCash after capex | -$10M | $49M |
| Gross MarginGross profit ÷ Revenue | +59.2% | +68.6% |
| Operating MarginEBIT ÷ Revenue | -18.8% | +25.1% |
| Net MarginNet income ÷ Revenue | -36.3% | +24.6% |
| FCF MarginFCF ÷ Revenue | -30.8% | +51.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +38.7% | -95.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.5% | -111.8% |
SIGA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
SIGA leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | BHSTBioHarvest Scienc… | SIGASIGA Technologies… |
|---|---|---|
| Market CapShares × price | $95M | $337M |
| Enterprise ValueMkt cap + debt − cash | $107M | -$154.97T |
| Trailing P/EPrice ÷ TTM EPS | -5.25x | 14.24x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 2.76x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | -6387033.21x |
| Price / SalesMarket cap ÷ Revenue | 3.78x | 3.56x |
| Price / BookPrice ÷ Book value/share | 51.14x | 0.00x |
| Price / FCFMarket cap ÷ FCF | — | 6.91x |
SIGA leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
SIGA leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
SIGA delivers a 0.0% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-12 for BHST. SIGA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BHST's 10.39x. On the Piotroski fundamental quality scale (0–9), BHST scores 6/9 vs SIGA's 5/9, reflecting solid financial health.
| Metric | BHSTBioHarvest Scienc… | SIGASIGA Technologies… |
|---|---|---|
| ROE (TTM)Return on equity | -12.0% | 0.0% |
| ROA (TTM)Return on assets | -41.5% | 0.0% |
| ROICReturn on invested capital | -70.4% | +0.0% |
| ROCEReturn on capital employed | -65.1% | 0.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 10.39x | 0.00x |
| Net DebtTotal debt minus cash | $11M | -$154.97T |
| Cash & Equiv.Liquid assets | $2M | $154.97T |
| Total DebtShort + long-term debt | $14M | $795,169 |
| Interest CoverageEBIT ÷ Interest expense | -1.10x | — |
SIGA leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
SIGA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SIGA five years ago would be worth $10,096 today (with dividends reinvested), compared to $8,400 for BHST. Over the past 12 months, SIGA leads with a +0.6% total return vs BHST's -35.9%. The 3-year compound annual growth rate (CAGR) favors SIGA at 6.8% vs BHST's -5.6% — a key indicator of consistent wealth creation.
| Metric | BHSTBioHarvest Scienc… | SIGASIGA Technologies… |
|---|---|---|
| YTD ReturnYear-to-date | -19.4% | -15.5% |
| 1-Year ReturnPast 12 months | -35.9% | +0.6% |
| 3-Year ReturnCumulative with dividends | -16.0% | +21.7% |
| 5-Year ReturnCumulative with dividends | -16.0% | +1.0% |
| 10-Year ReturnCumulative with dividends | -16.0% | +722.2% |
| CAGR (3Y)Annualised 3-year return | -5.6% | +6.8% |
SIGA leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — BHST and SIGA each lead in 1 of 2 comparable metrics.
Risk & Volatility
BHST is the less volatile stock with a 1.05 beta — it tends to amplify market swings less than SIGA's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SIGA currently trades 48.9% from its 52-week high vs BHST's 32.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | BHSTBioHarvest Scienc… | SIGASIGA Technologies… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 1.15x |
| 52-Week HighHighest price in past year | $12.80 | $9.62 |
| 52-Week LowLowest price in past year | $4.10 | $4.29 |
| % of 52W HighCurrent price vs 52-week peak | +32.8% | +48.9% |
| RSI (14)Momentum oscillator 0–100 | 43.1 | 44.0 |
| Avg Volume (50D)Average daily shares traded | 23K | 683K |
Evenly matched — BHST and SIGA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates BHST as "Buy" and SIGA as "Buy". SIGA is the only dividend payer here at 12.81% yield — a key consideration for income-focused portfolios.
| Metric | BHSTBioHarvest Scienc… | SIGASIGA Technologies… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $10.00 | — |
| # AnalystsCovering analysts | 1 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +12.8% |
| Dividend StreakConsecutive years of raises | — | 4 |
| Dividend / ShareAnnual DPS | — | $0.60 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
SIGA leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
Best OverallSIGA Technologies, Inc. (SIGA)Leads 4 of 6 categories
Loading custom metrics...
BHST vs SIGA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is BHST or SIGA a better buy right now?
For growth investors, BioHarvest Sciences Inc.
Common Stock (BHST) is the stronger pick with 98. 8% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate BioHarvest Sciences Inc. Common Stock (BHST) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BHST or SIGA?
Over the past 5 years, SIGA Technologies, Inc.
(SIGA) delivered a total return of +1. 0%, compared to -16. 0% for BioHarvest Sciences Inc. Common Stock (BHST). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus BHST's -16. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BHST or SIGA?
By beta (market sensitivity over 5 years), BioHarvest Sciences Inc.
Common Stock (BHST) is the lower-risk stock at 1. 05β versus SIGA Technologies, Inc. 's 1. 15β — meaning SIGA is approximately 9% more volatile than BHST relative to the S&P 500. On balance sheet safety, SIGA Technologies, Inc. (SIGA) carries a lower debt/equity ratio of 0% versus 10% for BioHarvest Sciences Inc. Common Stock — giving it more financial flexibility in a downturn.
04Which is growing faster — BHST or SIGA?
By revenue growth (latest reported year), BioHarvest Sciences Inc.
Common Stock (BHST) is pulling ahead at 98. 8% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: BioHarvest Sciences Inc. Common Stock grew EPS 14. 0% year-over-year, compared to -60. 2% for SIGA Technologies, Inc.. Over a 3-year CAGR, BHST leads at 128. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BHST or SIGA?
SIGA Technologies, Inc.
(SIGA) is the more profitable company, earning 24. 6% net margin versus -51. 3% for BioHarvest Sciences Inc. Common Stock — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -27. 7% for BHST. At the gross margin level — before operating expenses — SIGA leads at 68. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — BHST or SIGA?
In this comparison, SIGA (12.
8% yield) pays a dividend. BHST does not pay a meaningful dividend and should not be held primarily for income.
07Is BHST or SIGA better for a retirement portfolio?
For long-horizon retirement investors, SIGA Technologies, Inc.
(SIGA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 12. 8% yield, +722. 2% 10Y return). Both have compounded well over 10 years (SIGA: +722. 2%, BHST: -16. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between BHST and SIGA?
These companies operate in different sectors (BHST (Basic Materials) and SIGA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BHST is a small-cap high-growth stock; SIGA is a small-cap deep-value stock. SIGA pays a dividend while BHST does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(BHST: 38.7% · SIGA: -95.3%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.